Results 141 to 150 of about 23,932 (249)

COVID-19 vaccination readiness among multiple racial and ethnic groups in the San Francisco Bay Area: A qualitative analysis. [PDF]

PLoS One, 2022
Butler JZ, Carson M, Rios-Fetchko F, Vargas R, Cabrera A, Gallegos-Castillo A, LeSarre M, Liao M, Woo K, Ellis R, Liu K, Burra A, Ramirez M, Doyle B, Leung L, Fernandez A, Grumbach K.   +16 more
europepmc   +1 more source

Large‐scale bidirectional arrayed genetic screens identify OXR1 and EMC4 as modifiers of αSynuclein aggregation

FEBS Open Bio, Volume 16, Issue 8, Page 1563-1592, August 2026.
Activation of the mitochondrial protein OXR1 increases pSyn129 αSynuclein aggregation by lowering ATP levels and altering mitochondrial membrane potential, particularly in response to MSA‐derived fibrils. In contrast, ablation of the ER protein EMC4 enhances autophagic flux and lysosomal clearance, broadly reducing α‐synuclein aggregates.
Sandesh Neupane, Lea Nikolić, Lorenzo Maraio, Thomas Goiran, Nathan Karpilovsky, Stefano Sellitto, Vangelis Bouris, Jiang‐An Yin, Ronald Melki, Edward A Fon, Adriano Aguzzi, Elena De Cecco   +11 more
wiley   +1 more source

Prevalence and correlates of sexual intimate partner violence among trans women in the San Francisco Bay Area. [PDF]

Front Glob Womens Health
Santos GM, McFarland W, Wilson EC.
europepmc   +1 more source

Genome-Resolved Metagenomic Insights into Massive Seasonal Ammonia-Oxidizing Archaea Blooms in San Francisco Bay. [PDF]

mSystems, 2022
Rasmussen AN, Francis CA.
europepmc   +1 more source

Exploring longitudinal relationships among Alzheimer's disease biomarkers

Alzheimer's &Dementia, Volume 22, Issue 8, August 2026.
Abstract INTRODUCTION While most studies of Alzheimer's disease (AD) examine cross‐sectional relationships among biomarkers, longitudinal relationships are also highly relevant. METHODS This study in the Alzheimer's Disease Neuroimaging Initiative cohort (n = 373) used non‐parametric Spearman correlations to explore the relationships of baseline values
Benjamin Saef, Kellen K. Petersen, Katherine Volluz, Yan Li, Duygu Tosun, Marta Mila‐Aloma, Leslie M. Shaw, Henrik Zetterberg, Jeffrey L. Dage, Carrie E. Rubel, Kyle Ferber, Lei Du‐Cuny, Janaky Coomaraswamy, Michael Baratta, Yulia Mordashova, Ziad S. Saad, Gallen Triana‐Baltzer, Nicholas J. Ashton, Emily A. Meyers, Erin G. Rosenbaugh, J. Martin Sabandal, Anthony W. Bannon, William Z. Potter, Alzheimer's Disease Neuroimaging Initiative (ADNI), Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer's Disease Project Team, Suzanne E. Schindler   +25 more
wiley   +1 more source

Late Holocene Paleodietary Patterns Among the Ancestral Ohlone: Ecogeographic Partitioning of Resources Along the San Francisco Bay Eastern Shore. [PDF]

Am J Biol Anthropol
Beasley MM, Bartelink EJ, Leventhal A, Arellano MV, Massiatt R, Nijmeh C.   +5 more
europepmc   +1 more source

Genetic‐Proteomic Integration Identifies Predictive Plasma Proteins for Multiple Sclerosis

Annals of Neurology, Volume 100, Issue 2, Page 268-281, August 2026.
Objective Multiple sclerosis (MS) develops after a prolonged preclinical phase. Identifying circulating biomarkers that capture this early biology can improve risk stratification and guide intervention. We aimed to identify plasma proteins driving MS susceptibility using large‐scale proteogenomic integration and to evaluate their prediagnostic ...
Yuan Ding, Dylan Hamitouche, Simon Thebault, Patrick Kearns, Ahmed Abdelhak, Adil Harroud   +5 more
wiley   +1 more source

Spatial Trends and Health Risks of Per- and Polyfluoroalkyl Substances in San Francisco Bay Fish from 2009 to 2019. [PDF]

ACS ES T Water
Méndez MA, Davis J, Miller EL, Grace R, Sutton R.   +4 more
europepmc   +1 more source

Systematic Evaluation of Data and Trial Fitness for Oncology Trial Emulation: Empirical Findings from the CARE Initiative

Clinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 440-451, August 2026.
The Coalition to Advance Real‐World Evidence through Randomized Controlled Trial Emulation (CARE) Initiative seeks to advance understanding of when real‐world data (RWD) can generate valid treatment effectiveness estimates by emulating completed oncology randomized controlled trials (RCTs).
Natalie Levy, Paige Sheridan, Ulka Campbell, David Lenis, Inish O'Doherty, Adina Estrin, Nileesa Gautam, Monica Iyer, Sarah McDonald, Andrew Belli, Gillis Carrigan, K. Arnold Chan, James Chen, Victoria Chia, Neil Dhopeshwarkar, Joy Eckert, Laura Fernandes, Joel Greshock, Rachele Hendricks‐Sturrup, Jenny Huang, XiaoLong Jiao, Sajan Khosla, Orsolya Lunacsek, Lynn McRoy, Yanina Natanzon, Osayi Ovbiosa, Nelson Pace, Simone Pinheiro, Megan Rees, Jennifer Rider, Mothaffar Fahed Rimawi, Travis Robinson, Carla Rodriguez‐Watson, Chithra Sangli, Khaled Sarsour, Sebastian Schneeweiss, Mark Shapiro, Mark Stewart, Aliki Taylor, C. K. Wang, Shirley Wang, Yiduo Zhang, Ann Madsen   +42 more
wiley   +1 more source

COVID-19 Pandemic-Related Disruptions in Routine Cirrhosis Care and Associated Clinical Outcomes among San Francisco Bay Area Veterans. [PDF]

Gastro Hep Adv
Rubin JB, Loeb R, Monto A, Wong RJ, Cheung R, Batki SL, Ostacher MJ, Shen H, Hoggatt KJ, Satre DD, Khalili M.   +10 more
europepmc   +1 more source